liothyronine
liothyronine: sourced relationships with 1 company · 2 clinical trials tracked · 1 FDA decision.
liothyronine evidence translation
What we can confirm
1 FDA record · 2 tracked trials
What it means
What to watch
Prepared research question
How could liothyronine → RDY affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| DR REDDYS LABORATORIES LTD (RDY) Reported 2009-03-20 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (2)
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
Primary endpoint: TSH after two weeks of TH substitution
Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients With Recurrent Medulloblastoma and Ependymoma
Primary endpoint: 2-year event free survival (EFS) in the Recurrent Medulloblastoma Cohort
Frequently asked questions
Which companies have sourced relationships with liothyronine?
liothyronine has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD.
How many clinical trials involve liothyronine?
BioSniper tracks 2 clinical trials involving liothyronine.
What is liothyronine's latest FDA decision?
The most recent tracked FDA decision for liothyronine is Approval, dated March 20, 2009.